Manju Prasad, MD, MBBS, on Head and Neck Cancer Awareness Month
In recognition of Head and Neck Cancer Awareness Month, Manju Prasad, MD, MBBS, Professor of Pathology; Director, Endocrine Head and Neck Pathology Fellowship Program; Director, Endocrine Head and Neck Pathology, provides her insight.
Adebowale Adeniran, MD, on Kidney Cancer Awareness Month
In recognition of Kidney Cancer Awareness Month, Adebowale Adeniran, MD, Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Anatomic Pathology Elective Program in Pathology, explains how Yale Pathologists work with Smilow Cancer Hospital oncologists to enhance patient care and provide the best course of treatment.
Joanna Gibson, MD, PhD, on Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month, Joanna Gibson, MD, PhD, Associate Professor of Pathology and Director of Quality and Patient Safety at Yale Pathology, explains how Yale Pathologists collaborate with Smilow Cancer Hospital oncologists to determine the best therapeutic course for patients.
Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital
Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale New Haven Hospital.
Cancer Center Receives Two-pronged Gift
Christine Moog and Benoit Helluy are supporting the new Yale Center for Immuno-Oncology and Yale Cancer Center’s art therapy program. They see their gift as a way both to propel the science in an area where exciting new cancer treatments appear ready to emerge, and to make battling cancer a less-stressful challenge for patients and their loved ones.Source: Medicine@Yale
Doctors asking how much post-surgical follow-up is needed
On Saturday, Reisman, 52, a former New York lawyer who now freelances for the Shoreline Times, held a party to celebrate two decades of survival. Looking back on the years after her surgery, Reisman said the fear that the cancer could return was compounded by the anxiety she felt about the multiple MRIs she was required to undergo to make sure it hadn’t. Reisman’s experience has buttressed the concern of Dr. Cary Gross, her brother-in-law, a professor of medicine and epidemiology at the Yale School of Medicine. With new studies showing that multiple surveillance procedures don’t necessarily improve patient outcomes in at least some cancers, he is concerned about whether aggressive post-treatment testing is really necessary, given the anxiety, cost and even occasional false positive results that accompany it.Source: New Haven Register
Could Better Predictions Improve End-of-Life Care?
A team of Yale researchers has developed a statistical tool that can improve predictions of whether patients with advanced cancer are likely to die in the near term. Their analysis suggests that better understanding of the end of life could promote patient welfare by transferring more people from aggressive interventions to hospice care.Source: Yale Insights
Inspiring patient gives new meaning to the term “medical history”
Every three weeks, Ola Ferla spends a couple hours in the Smilow Cancer Hospital Apheresis unit, getting treated for a type of lymphoma. While physicians ask her questions, nurses and other staff buzz around her, taking vital signs, placing IVs and connecting Ferla to the machine that removes and treats her blood, then reintroduces it into her body. Ferla is unfazed by any of this, perhaps because she used to be a nurse – during World War II.
Art therapy: helping families cope with cancer
A new art therapy program at Yale Medicine Cancer Center is designed to help patients and their loved ones bond as well as to cope with fear and grief. Using a variety of tools and media, including pencils, pastels, markers, acrylic paint, collage and clay, the art therapist, Elizabeth Ferguson, helps patients and their families express strong feelings.Source: Yale Medicine